Elizabeth Ashley Hardin, M.D.
Internal Medicine, Advanced Heart Failure and Transplant Cardiology (M.D.) in Dallas, Texas, trained at University of Texas Southwestern Medical School at Dallas (class of 2010). Their prescriptions cost Medicare Part D more than their services did: $1,403,151 for 1,217 claims, against $67,938 paid for services in 2024. Actelion Pharmaceuticals US, Inc. was the largest of 2 companies reporting payments in 2025, $106.35 in all, mostly food and beverage.
Overview
| NPI | 1174849566 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Apr 11, 2010 |
| Last updated in NPPES | May 9, 2019 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology Primary | 207RA0001X | R3524 | TX |
| Student in an Organized Health Care Education/Training Program | 390200000X | — | — |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Advanced Heart Failure and Transplant Cardiology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 864 |
|---|---|
| Services billed | 1,546 across 23 procedure codes |
| Paid by Medicare | $67,938 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,217 · 2,291 30-day fills |
|---|---|
| Patients | 237 |
| Total drug cost | $1,403,151 |
| Generic share | 79% of claims |
Education and affiliations
| Medical school | University of Texas Southwestern Medical School at Dallas |
|---|---|
| Graduation year | 2010 |
| Medicare specialty | Advanced Heart Failure And Transplant Cardiology |
| Secondary specialties | Cardiovascular Disease (Cardiology), Internal Medicine |
| Telehealth | Offers telehealth |
Medical group
- University of Texas Southwestern Medical Center at DallasDallas, TX · 3,187 clinicians
Hospital affiliation
Industry payments (Open Payments)
- 2025$106.35 · 2 payments from 2 companies
- 2024$77.30 · 3 payments from 3 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $53.32 | 1 |
| Abbott Laboratories | $53.03 | 1 |
What the 2025 payments were for
- Food and Beverage$106.35 · 2 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Dallas
- 1972846285
- 1588906986
- 1205045184
- 1033118278
- 1285699009
- 1700976974
- 1386855922
- 1750511820
- 1912961145
- 1043606502
- 1518353911
- 1326571902
All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Texas →